Price To Earnings Ratio 50.45 | Sector PE 71.67 |
PB Ratio 16.56 | Sector PB 9.22 |
EPS 565.28 | Dividend Yield 1.52 |
Today's Volume 3.294 K | 5 Day Avg. Volume 8.280 K |
PEG Ratio 1.90 | Market Cap. ₹ 58,910.00 Cr. |
Time | ABBOTINDIA | VS | Industry |
---|---|---|---|
1 Day | 0.4% | -1.57% | |
1 Week | 4.73% | -0.71% | |
1 Month | 0.04% | -0.68% | |
6 Months | 1.49% | 19.22% | |
1 Year | 23.98% | 40.44% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 27696.63 | Bullish |
20 | 27535.61 | Bullish |
30 | 27829.31 | Bullish |
50 | 28024.2 | Bullish |
100 | 28245.92 | Bullish |
200 | 27984.8 | Bullish |
Annual | FY 2001 | ||
---|---|---|---|
Operating Activities | 35.49 | ||
Investing Activities | 0.55 | ||
Financing Activities | -27.02 | ||
Net Cash Flow | 9.02 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
Abbott India | 0.4 | 4.73 | 0.04 | 1.49 | 23.98 |
Alembic | -0.87 | 4.08 | 1.29 | 2.51 | 2.51 |
Aurobindo Pharma | 1.41 | -0.57 | -10.08 | -10.84 | 14.22 |
Fortis Healthcare | 2.64 | 7.72 | 17.12 | 47.18 | 78.55 |
Ajanta Pharmaceuticals | -1.34 | -5.51 | -8.71 | 12.47 | 38.64 |
Abbott India Limited is an Indian pharmaceutical company. The company has a range of diagnostics, medical devices, nutritional products and branded generics. It offers products and solutions for various therapeutic areas such as women's and #x27 health, gastroenterology, central nervous system, metabolic, multidisciplinary, vaccines and consumer health. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (abortion and IVF), Duphalac (disease), Digene (antacid), Prothiaden (pain and depression), Influvac (flu prevention), Creon (pancreatic insufficiency), Cremalax (failure), Pankreoflat (indigestion) and Duvadilan (late labor). It offers a variety of products under brand names such as Similac, PediaSure, Pedialyte, EleCare, Ensure and Glucerna.